Lexaria Bioscience Corp. (LEXX)
NASDAQ: LEXX · Real-Time Price · USD
0.701
-0.128 (-15.42%)
Mar 9, 2026, 3:48 PM EDT - Market open
Lexaria Bioscience Market Cap
Lexaria Bioscience has a market cap or net worth of $17.45 million as of March 9, 2026. Its market cap has decreased by -30.49% in one year.
Market Cap
17.45M
Enterprise Value
13.56M
1-Year Change
-30.49%
Ranking
Category
Stock Price
$0.70
Market Cap Chart
Since February 12, 2007, Lexaria Bioscience's market cap has decreased from $19.40M to $17.45M, a decrease of -10.07%. That is a compound annual growth rate of -0.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 20.60M | 50.36% |
| Dec 31, 2025 | 13.70M | -62.67% |
| Dec 31, 2024 | 36.70M | 186.72% |
| Dec 29, 2023 | 12.80M | -12.33% |
| Dec 30, 2022 | 14.60M | -36.80% |
| Dec 31, 2021 | 23.10M | 2.67% |
| Dec 31, 2020 | 22.50M | -24.75% |
| Dec 31, 2019 | 29.90M | -58.30% |
| Dec 31, 2018 | 71.70M | -38.87% |
| Dec 29, 2017 | 117.30M | 624.07% |
| Dec 30, 2016 | 16.20M | 131.43% |
| Dec 31, 2015 | 7.00M | 125.81% |
| Dec 31, 2014 | 3.10M | 342.86% |
| Dec 31, 2013 | 700.00K | -12.50% |
| Dec 31, 2012 | 800.00K | -77.78% |
| Dec 30, 2011 | 3.60M | -7.69% |
| Dec 31, 2010 | 3.90M | 69.57% |
| Dec 31, 2009 | 2.30M | 130.00% |
| Dec 31, 2008 | 1.00M | -94.71% |
| Dec 31, 2007 | 18.90M | -2.58% |
View and export this data all the way back to 2007.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Daré Bioscience | 21.86M |
| IO Biotech | 21.62M |
| Lixte Biotechnology Holdings | 21.26M |
| Polyrizon | 20.90M |
| Reviva Pharmaceuticals Holdings | 20.87M |
| NanoViricides | 20.72M |
| Genenta Science | 20.15M |
| Intensity Therapeutics | 20.14M |